ArticleScientific reports2026
Health-related quality of life and visual function in retinoblastoma survivors with ocular prostheses: a cross-sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinoblastoma (RB) survivors who have undergone enucleation and use ocular prostheses may face long-term challenges related to visual function and overall well-being. This study aimed to evaluate health-related quality of life (HR-QoL) and visual function in this population, addressing a gap in knowledge regarding their lived experiences and functional vision. This cross-sectional study included 12 unilateral and 3 bilateral RB survivors (10 girls, 5 boys; mean age 15.5 years, range 6.8-26.5), all treated with unilaterally enucleation and an ocular prosthesis at Sahlgrenska University Hospital, Sweden (2000-2019). HR-QoL was assessed using the Paediatric Quality of Life Inventory (PedsQL), both self- and parent-reports. Functional vision was evaluated by best-corrected visual acuity (BCVA) and structured history-taking of perceptual visual dysfunctions (PVDs). Results were compared with age-matched healthy controls. Self-reported PedsQL total score (82.5) equalled normative data (83.0) and parents' report (82.5). Parents' reports were comparable to published parental norms (82.5 vs. 87.6). Survivors with subnormal BCVA (≥ 0.2 LogMAR) had significantly lower self-reported HR-QoL scores than those with normal vision (64.1 vs. 88.0, p = 0.014), a difference not reflected in parent-reports. Survivors reported more PVDs ≥ 1 area (median 1, range 1-4) than controls (9/15 vs. 1/15, p = 0.005). The number of affected PVD areas correlated with age (r = 0.59, p = 0.022), but not with BCVA or PedsQL score. RB survivors with ocular prostheses require holistic care that includes assessment of HR-QoL and functional vision, beyond visual acuity, to identify unmet needs and guide interventions that support overall well-being and optimal long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.